Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C (Q36753716)
scientific article published on May 1, 1991
Language:
(P31) (Q13442814)
(P50) (Q56616768)
(P304) 873-878
(P407) (Q1860)
(P433) 5
(P478) 35
(P577) Wednesday, May 1, 1991
(P921) (Q12187)
(Q408529)
(Q128406)
(P953) https://europepmc.org/articles/PMC245122
https://europepmc.org/articles/PMC245122?pdf=render
https://journals.asm.org/doi/pdf/10.1128/AAC.35.5.873
(P1433) (Q578004)
(P1476) "Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C" (language: en)
"Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group" (language: en)
(P2093) F. Meunier
S. H. Zinner
H. Gaya
C. Viscoli
J. Klastersky
M. Glauser
(P2860) (Q40337576)
(Q35641123)
(Q40801133)
(Q35651131)
(Q40805848)
(Q39828366)
(Q38756574)
(Q38756565)
(Q40366767)
(Q54415561)
(Q43788709)
(Q43487859)
(Q54511340)
(Q71730985)
(Q69411383)
(Q64132969)
(Q70139353)
other details
description scientific article published on May 1, 1991

External Links